51. Inflammatory pathways regulated by tumor necrosis receptor-associated factor 1 protect from metabolic consequences in diet-induced obesity
- Author
-
Dennis Wolf, Natalie Hoppe, Florian Willecke, Timoteo Marchini, Roland Schüle, Akula Bala Pramod, Timo Heidt, Peter Stachon, Ingo Hilgendorf, Christoph Bode, Andreas Zirlik, Christian Colberg, Konrad Buscher, Erik Ehinger, Ulrich Kintscher, Katharina Pfeiffer, Dietmar Pfeifer, Nathaly Anto Michel, Sebastian Brachs, Klaus Ley, Bianca Dufner, Constantin von zur Mühlen, Dominik von Elverfeldt, and Björn Sommer
- Subjects
Male ,0301 basic medicine ,medicine.medical_specialty ,Chemokine ,CIENCIAS MÉDICAS Y DE LA SALUD ,Physiology ,Inmunología ,Adipose tissue ,Adipokine ,Inflammation ,Diet, High-Fat ,Article ,Proinflammatory cytokine ,Mice ,03 medical and health sciences ,chemistry.chemical_compound ,Adipocyte ,Internal medicine ,Adipocytes ,medicine ,Animals ,Obesity ,Cells, Cultured ,Uncoupling Protein 1 ,METABOLIC SYNDROME ,biology ,business.industry ,Interleukin ,Thermogenesis ,Lipid Metabolism ,TNF Receptor-Associated Factor 1 ,ADIPOCYTES ,Mice, Inbred C57BL ,MICE ,Medicina Básica ,030104 developmental biology ,Endocrinology ,chemistry ,OBESITY ,biology.protein ,Tumor necrosis factor alpha ,Insulin Resistance ,medicine.symptom ,Cardiology and Cardiovascular Medicine ,business ,LIPOLYSIS - Abstract
Rationale: The coincidence of inflammation and metabolic derangements in obese adipose tissue has sparked the concept of met-inflammation. Previous observations, however, suggest that inflammatory pathways may not ultimately cause dysmetabolism. Objective: We have revisited the relationship between inflammation and metabolism by testing the role of TRAF (tumor necrosis receptor-associated factor)-1, an inhibitory adapter of inflammatory signaling of TNF (tumor necrosis factor)-a, IL (interleukin)-1ß, and TLRs (toll-like receptors). Methods and Results: Mice defcient for TRAF-1, which is expressed in obese adipocytes and adipose tissue lymphocytes, caused an expected hyperinflammatory phenotype in adipose tissue with enhanced adipokine and chemokine expression, increased leukocyte accumulation, and potentiated proinflammatory signaling in macrophages and adipocytes in a mouse model of diet-induced obesity. Unexpectedly, TRAF-1-/-mice were protected from metabolic derangements and adipocyte growth, failed to gain weight, and showed improved insulin resistance-an effect caused by increased lipid breakdown in adipocytes and UCP (uncoupling protein)-1-enabled thermogenesis. TRAF-1-dependent catabolic and proinflammatory cues were synergistically driven by ß3-adrenergic and inflammatory signaling and required the presence of both TRAF-1-defcient adipocytes and macrophages. In human obesity, TRAF-1-dependent genes were upregulated. Conclusions: Enhancing TRAF-1-dependent inflammatory pathways in a gain-of-function approach protected from metabolic derangements in diet-induced obesity. These fndings identify TRAF-1 as a regulator of dysmetabolism in mice and humans and question the pathogenic role of chronic inflammation in metabolism. Fil: Michel, Nathaly Anto. University of Freiburg. University Medical Center; Alemania Fil: Colberg, Christian. University of Freiburg. University Medical Center; Alemania Fil: Buscher, Konrad. La Jolla Institute for Allergy and Immunology; Estados Unidos Fil: Sommer, Björn. Universitat Erlangen-Nuremberg; Alemania Fil: Pramod, Akula Bala. La Jolla Institute for Allergy and Immunology; Estados Unidos Fil: Ehinger, Erik. La Jolla Institute for Allergy and Immunology; Estados Unidos Fil: Dufner, Bianca. University of Freiburg. University Medical Center; Alemania Fil: Hoppe, Natalie. University of Freiburg. University Medical Center; Alemania Fil: Pfeiffer, Katharina. University of Freiburg. University Medical Center; Alemania Fil: Marchini, Timoteo Oscar. University of Freiburg. University Medical Center; Alemania. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Bioquímica y Medicina Molecular. Universidad de Buenos Aires. Facultad Medicina. Instituto de Bioquímica y Medicina Molecular; Argentina Fil: Willecke, Florian. University of Freiburg. University Medical Center; Alemania Fil: Stachon, Peter. University of Freiburg. University Medical Center; Alemania Fil: Hilgendorf, Ingo. University of Freiburg. University Medical Center; Alemania Fil: Heidt, Timo. University of Freiburg. University Medical Center; Alemania Fil: Von Zur Muhlen, Constantin. University of Freiburg. University Medical Center; Alemania Fil: Von Elverfeldt, Dominik. University of Freiburg. University Medical Center; Alemania Fil: Pfeifer, Dietmar. University of Freiburg; Alemania Fil: Schüle, Roland. University of Freiburg; Alemania Fil: Kintscher, Ulrich. University of Freiburg; Alemania Fil: Brachs, Sebastian. Center For Cardiovascular Research; Alemania Fil: Ley, Klaus. La Jolla Institute for Allergy and Immunology; Estados Unidos Fil: Bode, Christoph. University of Freiburg. University Medical Center; Alemania Fil: Zirlik, Andreas. University of Freiburg. University Medical Center; Alemania Fil: Wolf, Dennis. La Jolla Institute for Allergy and Immunology; Estados Unidos
- Published
- 2018
- Full Text
- View/download PDF